Loading insider details...
Beta
Latest Form 4 (Jul 1, 2026): Disposition to Issuer of 244 APTO shares, $419.68.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 1, 2026 | Aptose Biosciences Inc. (APTO) | Disposition to Issuer | 244 | $419.68 |
| Feb 7, 2024 | Aptose Biosciences Inc. (APTO) | Grant/Award | 35,000 | n/a |
| Jan 24, 2023 | Aptose Biosciences Inc. (APTO) | Grant/Award | 100,000 | n/a |
| Jan 20, 2022 | Aptose Biosciences Inc. (APTO) | Grant/Award | 600,000 | n/a |
| Nov 20, 2021 | Aptose Biosciences Inc. (APTO) | Purchase | 10,000 | $25.6K |
| Aug 23, 2021 | Aptose Biosciences Inc. (APTO) | Grant/Award | 200,000 | n/a |
| Jan 6, 2021 | Aptose Biosciences Inc. (APTO) | Grant/Award | 343,000 | n/a |
| Feb 4, 2020 | Aptose Biosciences Inc. (APTO) | Grant/Award | 200,000 | n/a |
| Jan 3, 2020 | Aptose Biosciences Inc. (APTO) | Grant/Award | 400,000 | n/a |